LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 71.54 | 771.67 | 4604 | 10532 | 0.4371 | 0.6059 | MN20160304_L01 | L15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 73.76 | 771.67 | 5177 | 10851 | 0.4771 | 0.6472 | MN20160304_L01 | J22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 73.76 | 771.67 | 4794 | 10851 | 0.4418 | 0.6144 | MN20160304_L01 | L15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 76.02 | 771.67 | 5362 | 11106 | 0.4828 | 0.6551 | MN20160304_L01 | J22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 76.02 | 771.67 | 4977 | 11106 | 0.4481 | 0.6234 | MN20160304_L01 | L15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 78.25 | 771.67 | 5568 | 11367 | 0.4898 | 0.6640 | MN20160304_L01 | J22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 78.25 | 771.67 | 5230 | 11367 | 0.4601 | 0.6374 | MN20160304_L01 | L15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 80.48 | 771.67 | 5734 | 11685 | 0.4907 | 0.6679 | MN20160304_L01 | J22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 80.48 | 771.67 | 5481 | 11685 | 0.4691 | 0.6488 | MN20160304_L01 | L15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 82.69 | 771.67 | 5933 | 11974 | 0.4955 | 0.6747 | MN20160304_L01 | J22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 82.69 | 771.67 | 5608 | 11974 | 0.4684 | 0.6510 | MN20160304_L01 | L15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 84.92 | 771.67 | 6130 | 12266 | 0.4997 | 0.6809 | MN20160304_L01 | J22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 84.92 | 771.67 | 5821 | 12266 | 0.4745 | 0.6592 | MN20160304_L01 | L15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 87.14 | 771.67 | 6357 | 12592 | 0.5048 | 0.6879 | MN20160304_L01 | J22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 87.14 | 771.67 | 6105 | 12592 | 0.4848 | 0.6710 | MN20160304_L01 | L15 |
MCF 10A-H2B-mCherry | Dasatinib | 1 | 2.49 | 771.67 | 731 | 867 | 0.8424 | -0.2737 | MN20160304_L01 | E05 |
MCF 10A-H2B-mCherry | Dasatinib | 1 | 2.49 | 771.67 | 783 | 867 | 0.9023 | 0.0899 | MN20160304_L01 | G04 |
MCF 10A-H2B-mCherry | Dasatinib | 1 | 4.71 | 771.67 | 841 | 956 | 0.8794 | 0.3204 | MN20160304_L01 | E05 |
MCF 10A-H2B-mCherry | Dasatinib | 1 | 4.71 | 771.67 | 907 | 956 | 0.9484 | 0.6853 | MN20160304_L01 | G04 |
MCF 10A-H2B-mCherry | Dasatinib | 1 | 6.94 | 771.67 | 937 | 1045 | 0.8965 | 0.5583 | MN20160304_L01 | E05 |
MCF 10A-H2B-mCherry | Dasatinib | 1 | 6.94 | 771.67 | 1002 | 1045 | 0.9587 | 0.8164 | MN20160304_L01 | G04 |
MCF 10A-H2B-mCherry | Dasatinib | 1 | 9.16 | 771.67 | 1001 | 1138 | 0.8792 | 0.5900 | MN20160304_L01 | E05 |
MCF 10A-H2B-mCherry | Dasatinib | 1 | 9.16 | 771.67 | 1067 | 1138 | 0.9372 | 0.7817 | MN20160304_L01 | G04 |
MCF 10A-H2B-mCherry | Dasatinib | 1 | 11.56 | 771.67 | 1150 | 1280 | 0.8980 | 0.7262 | MN20160304_L01 | E05 |
MCF 10A-H2B-mCherry | Dasatinib | 1 | 11.56 | 771.67 | 1191 | 1280 | 0.9300 | 0.8110 | MN20160304_L01 | G04 |